Birdwatch Note
2023-04-24 15:57:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Emergency use authorizations were used to bring vaccines to clinical use at a time when rapid progress in tackling the pandemic was vital to save lives. They do not exempt the manufacturer from providing clinical safety data, not render them immune to prosecution. https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained
Written by 90416E1B6428DAC3DEE3425B5DE230C9667981195596BEF73A633C6C646107CD
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1650378317504159744
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1650529506560442368
- noteId - 1650529506560442368
- participantId -
- noteAuthorParticipantId - 90416E1B6428DAC3DEE3425B5DE230C9667981195596BEF73A633C6C646107CD Participant Details
- createdAtMillis - 1682351874377
- tweetId - 1650378317504159744
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Emergency use authorizations were used to bring vaccines to clinical use at a time when rapid progress in tackling the pandemic was vital to save lives. They do not exempt the manufacturer from providing clinical safety data, not render them immune to prosecution. https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-24 15:57:54 UTC (1682351874377) |
1969-12-31 23:59:59 UTC (-1) |
2023-05-06 02:42:24 UTC (1683340944665) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-05-04 09:13:04 -0500 | Rating Details | |
2023-04-24 16:03:02 -0500 | Rating Details | |
2023-04-24 16:10:14 -0500 | Rating Details | |
2023-04-24 13:28:30 -0500 | Rating Details | |
2023-04-24 11:06:00 -0500 | Rating Details | |
2023-04-24 14:38:12 -0500 | Rating Details | |
2023-04-24 15:28:29 -0500 | Rating Details | |
2023-04-24 15:29:45 -0500 | Rating Details | |
2023-04-24 15:10:18 -0500 | Rating Details | |
2023-04-24 15:13:28 -0500 | Rating Details | |
2023-04-24 16:44:32 -0500 | Rating Details | |
2023-04-24 14:04:32 -0500 | Rating Details | |
2023-04-24 15:17:21 -0500 | Rating Details | |
2023-04-24 15:11:59 -0500 | Rating Details | |
2023-04-24 14:00:12 -0500 | Rating Details | |
2023-04-24 13:09:36 -0500 | Rating Details | |
2023-04-24 15:44:56 -0500 | Rating Details | |
2023-04-24 14:52:28 -0500 | Rating Details | |
2023-04-24 14:50:04 -0500 | Rating Details | |
2023-04-24 14:21:20 -0500 | Rating Details | |
2023-04-24 15:50:09 -0500 | Rating Details | |
2023-04-24 14:39:34 -0500 | Rating Details | |
2023-04-24 16:03:26 -0500 | Rating Details | |
2023-04-24 14:07:36 -0500 | Rating Details | |
2023-04-24 12:56:21 -0500 | Rating Details | |
2023-04-24 15:28:53 -0500 | Rating Details | |
2023-04-24 13:53:29 -0500 | Rating Details | |
2023-04-24 13:36:53 -0500 | Rating Details | |
2023-04-24 14:26:22 -0500 | Rating Details | |
2023-04-24 15:05:34 -0500 | Rating Details | |
2023-04-25 11:51:39 -0500 | Rating Details | |
2023-04-24 13:48:38 -0500 | Rating Details | |
2023-04-24 13:44:09 -0500 | Rating Details | |
2023-04-24 15:09:14 -0500 | Rating Details | |
2023-04-24 13:21:30 -0500 | Rating Details | |
2023-04-24 15:26:44 -0500 | Rating Details | |
2023-04-24 15:35:35 -0500 | Rating Details | |
2023-04-24 15:57:56 -0500 | Rating Details | |
2023-04-24 15:31:23 -0500 | Rating Details | |
2023-04-24 13:54:19 -0500 | Rating Details | |
2023-04-24 15:43:08 -0500 | Rating Details | |
2023-04-24 16:26:01 -0500 | Rating Details | |
2023-04-24 14:12:49 -0500 | Rating Details | |
2023-04-24 16:14:02 -0500 | Rating Details | |
2023-04-24 14:23:16 -0500 | Rating Details | |
2023-04-24 15:05:56 -0500 | Rating Details | |
2023-04-24 16:50:16 -0500 | Rating Details | |
2023-04-24 14:00:23 -0500 | Rating Details | |
2023-04-24 13:47:25 -0500 | Rating Details | |
2023-04-24 16:00:53 -0500 | Rating Details | |
2023-04-24 13:34:47 -0500 | Rating Details | |
2023-04-24 15:42:48 -0500 | Rating Details | |
2023-04-24 14:15:24 -0500 | Rating Details | |
2023-04-24 13:48:58 -0500 | Rating Details | |
2023-04-24 15:54:16 -0500 | Rating Details | |
2023-04-24 16:08:20 -0500 | Rating Details | |
2023-04-24 16:04:09 -0500 | Rating Details | |
2023-04-24 15:45:32 -0500 | Rating Details | |
2023-04-24 14:10:10 -0500 | Rating Details | |
2023-04-24 14:07:10 -0500 | Rating Details | |
2023-04-24 16:24:59 -0500 | Rating Details | |
2023-04-24 15:59:29 -0500 | Rating Details | |
2023-04-24 14:20:45 -0500 | Rating Details | |
2023-04-24 15:01:26 -0500 | Rating Details | |
2023-04-24 13:42:05 -0500 | Rating Details | |
2023-04-24 15:41:09 -0500 | Rating Details | |
2023-04-24 15:35:33 -0500 | Rating Details | |
2023-04-24 13:49:07 -0500 | Rating Details | |
2023-04-24 16:03:02 -0500 | Rating Details | |
2023-04-24 16:10:14 -0500 | Rating Details | |
2023-04-24 13:28:30 -0500 | Rating Details | |
2023-04-24 11:06:00 -0500 | Rating Details | |
2023-04-24 14:38:12 -0500 | Rating Details | |
2023-04-24 15:28:29 -0500 | Rating Details | |
2023-04-24 15:29:45 -0500 | Rating Details | |
2023-04-24 15:10:18 -0500 | Rating Details | |
2023-04-24 15:13:28 -0500 | Rating Details | |
2023-04-24 16:44:32 -0500 | Rating Details | |
2023-04-24 14:04:32 -0500 | Rating Details | |
2023-04-24 15:17:21 -0500 | Rating Details | |
2023-04-24 15:11:59 -0500 | Rating Details | |
2023-04-24 14:00:12 -0500 | Rating Details | |
2023-04-24 13:09:36 -0500 | Rating Details | |
2023-04-24 15:44:56 -0500 | Rating Details | |
2023-04-24 14:52:28 -0500 | Rating Details | |
2023-04-24 14:50:04 -0500 | Rating Details | |
2023-04-24 14:21:20 -0500 | Rating Details | |
2023-04-24 15:50:09 -0500 | Rating Details | |
2023-04-24 14:39:34 -0500 | Rating Details | |
2023-05-04 09:13:04 -0500 | Rating Details | |
2023-04-24 16:03:26 -0500 | Rating Details | |
2023-04-24 14:07:36 -0500 | Rating Details | |
2023-04-24 12:56:21 -0500 | Rating Details | |
2023-04-24 15:28:53 -0500 | Rating Details | |
2023-04-24 13:53:29 -0500 | Rating Details | |
2023-04-24 13:36:53 -0500 | Rating Details | |
2023-04-24 14:26:22 -0500 | Rating Details | |
2023-04-24 15:05:34 -0500 | Rating Details | |
2023-04-25 11:51:39 -0500 | Rating Details | |
2023-04-24 13:48:38 -0500 | Rating Details | |
2023-04-24 13:44:09 -0500 | Rating Details | |
2023-04-24 15:09:14 -0500 | Rating Details | |
2023-04-24 13:21:30 -0500 | Rating Details | |
2023-04-24 15:26:44 -0500 | Rating Details | |
2023-04-24 15:35:35 -0500 | Rating Details | |
2023-04-24 15:57:56 -0500 | Rating Details | |
2023-04-24 15:31:23 -0500 | Rating Details | |
2023-04-24 13:54:19 -0500 | Rating Details | |
2023-04-24 15:43:08 -0500 | Rating Details | |
2023-04-24 16:26:01 -0500 | Rating Details | |
2023-04-24 14:12:49 -0500 | Rating Details | |
2023-04-24 16:14:02 -0500 | Rating Details | |
2023-04-24 14:23:16 -0500 | Rating Details | |
2023-04-24 15:05:56 -0500 | Rating Details | |
2023-04-24 16:50:16 -0500 | Rating Details | |
2023-04-24 14:00:23 -0500 | Rating Details | |
2023-04-24 13:47:25 -0500 | Rating Details | |
2023-04-24 16:00:53 -0500 | Rating Details | |
2023-04-24 13:34:47 -0500 | Rating Details | |
2023-04-24 15:42:48 -0500 | Rating Details | |
2023-04-24 14:15:24 -0500 | Rating Details | |
2023-04-24 13:48:58 -0500 | Rating Details | |
2023-04-24 15:54:16 -0500 | Rating Details | |
2023-04-24 16:08:20 -0500 | Rating Details | |
2023-04-24 16:04:09 -0500 | Rating Details | |
2023-04-24 15:45:32 -0500 | Rating Details | |
2023-04-24 14:10:10 -0500 | Rating Details | |
2023-04-24 14:07:10 -0500 | Rating Details | |
2023-04-24 16:24:59 -0500 | Rating Details | |
2023-04-24 15:59:29 -0500 | Rating Details | |
2023-04-24 14:20:45 -0500 | Rating Details | |
2023-04-24 15:01:26 -0500 | Rating Details | |
2023-04-24 13:42:05 -0500 | Rating Details | |
2023-04-24 15:41:09 -0500 | Rating Details | |
2023-04-24 15:35:33 -0500 | Rating Details | |
2023-04-24 13:49:07 -0500 | Rating Details |